🇺🇸 FDA

Company profile · Sponsor

Allarity

Allarity Therapeutics

ALLR · NYSE pharma BOSTON, MA, USA
Pipeline
7
Drugs
0
Patents
1

Quick answer

Allarity (ALLR) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker ALLR
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0001860657

Pipeline (7)

Search pipeline →

  1. 2X-121

    Allarity

    Advanced Ovarian Cancer

    phase 2 small molecule active

    1 trial

  2. APO010

    Allarity

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  3. Irofulven

    Allarity

    Metastatic Castration-Resistant Prostate Cancer Patients

    phase 2 small molecule completed

    1 trial

  4. Ixabepilone Injection

    Allarity

    Metastatic Breast Cancer

    phase 2 small molecule terminated

    1 trial

  5. LiPlaCis

    Allarity

    Phase 1: Advanced or Refractory Solid Tumours

    phase 2 small molecule completed

    1 trial

  6. PARP inhibitor 2X-121

    Allarity

    Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial

  7. 2X-121 and dovitinib

    Allarity

    Advanced Solid Tumors

    phase 1 small molecule on hold

    1 trial

Patents (1)

Search patents →

  1. US 11421284

    Methods for predicting drug responsiveness in cancer patients

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Allarity?

Allarity (ALLR) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Allarity sponsor?

We track 7 ClinicalTrials.gov-linked programs for Allarity, including 2X-121 and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Allarity company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.